ADVFN Logo ADVFN

Não encontramos resultados para:
Verifique se escreveu corretamente ou tente ampliar sua busca.

Tendências Agora

Rankings

Parece que você não está logado.
Clique no botão abaixo para fazer login e ver seu histórico recente.

Cadastre-se

Já é membro? Faça login

Moneta Markets

Abrir Conta

Moneta Markets
Dados
Notícias
Ferramentas
Mercados
Comunidade

Hot Features

Follow Feed

Conecte-se com traders e investidores em nossa comunidade Follow Feed.

Fluxo de Opções

Explore dados abrangentes de opções e utilize filtros avançados com Fluxo de Opções.

Monitor

Organize e monitore sua lista de ações e ativos com o Monitor.
Entrar Premium IconPremium Help Menu
Índice Bovespa
128.150,71
-0,10%
S&P 500
5.303,27
0,12%
US Dollar vs BRL
5,1047
-0,50%
Bitcoin
67.008,97
2,71%
Brent Oil
83,76
0,67%
Registration Strip Icon for default Cadastre-se gratuitamente para obter cotações em tempo real, gráficos interativos, fluxo de opções ao vivo e muito mais.
Cadastre-se
  1. Início
  2. Investir
  3. Ações
  4. EUA
  5. NASDAQ
  6. Biora Therapeutics Inc (PROG)

  7. Biora Therapeutics Inc (PROG) Notícias

PROG

Biora Therapeutics (PROG)

Biora Therapeutics Inc
De:
Ordenação:
 Apresentando as notícias mais relevantes sobre:NASDAQ:PROG
DataHoraFonteTítuloCódigoCompanhia
16/06/202317:08Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:PROGBiora Therapeutics Inc
15/06/202317:32Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:PROGBiora Therapeutics Inc
13/06/202311:26Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)NASDAQ:PROGBiora Therapeutics Inc
13/06/202311:26Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)NASDAQ:PROGBiora Therapeutics Inc
27/04/202317:41Edgar (US Regulatory)Annual Report to Security Holders (ars)NASDAQ:PROGBiora Therapeutics Inc
27/04/202317:34Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:PROGBiora Therapeutics Inc
13/03/202317:19Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NASDAQ:PROGBiora Therapeutics Inc
27/01/202319:02Edgar (US Regulatory)Securities Registration Statement (simplified Form) (s-3)NASDAQ:PROGBiora Therapeutics Inc
09/12/202219:04Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:PROGBiora Therapeutics Inc
10/11/202219:06Edgar (US Regulatory)Proxy Statement - Notice of Shareholders Meeting (preliminary) (pre 14a)NASDAQ:PROGBiora Therapeutics Inc
10/05/202217:44Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:PROGBiora Therapeutics Inc
05/05/202207:30GlobeNewswire Inc.Progenity Announces Successful Transfer of Liquid Biopsy TechnologiesNASDAQ:PROGBiora Therapeutics Inc
03/05/202210:00GlobeNewswire Inc.Progenity to Report First Quarter Financial Results and Provide Corporate Update as Biora Therapeutics, Inc.NASDAQ:PROGBiora Therapeutics Inc
25/04/202210:00GlobeNewswire Inc.Progenity Appoints Paul Shabram to Lead Technical Operations of the Company’s Ingestible Drug/Device PlatformsNASDAQ:PROGBiora Therapeutics Inc
12/04/202210:00GlobeNewswire Inc.Progenity to Become Biora Therapeutics as it Completes TransformationNASDAQ:PROGBiora Therapeutics Inc
06/04/202210:00GlobeNewswire Inc.Progenity Announces Two Poster Presentations at Controlled Release Society 2022NASDAQ:PROGBiora Therapeutics Inc
29/03/202223:27TipRanksRobert W. Baird Keeps a Hold Rating on Progenity (PROG)NASDAQ:PROGBiora Therapeutics Inc
29/03/202209:25TipRanksH.C. Wainwright Reaffirms Their Buy Rating on Progenity (PROG)NASDAQ:PROGBiora Therapeutics Inc
28/03/202218:18Edgar (US Regulatory)Securities Registration: Employee Benefit Plan (s-8)NASDAQ:PROGBiora Therapeutics Inc
28/03/202217:39Edgar (US Regulatory)Annual Report (10-k)NASDAQ:PROGBiora Therapeutics Inc
28/03/202217:01GlobeNewswire Inc.Progenity Provides Corporate Update and Reports Fourth Quarter and Full Year 2021 Financial ResultsNASDAQ:PROGBiora Therapeutics Inc
16/03/202217:23GlobeNewswire Inc.Progenity to Report Fourth Quarter and Full-Year 2021 Financial Results and Provide Corporate UpdateNASDAQ:PROGBiora Therapeutics Inc
10/03/202213:45TipRanksH.C. Wainwright Thinks Progenity’s Stock is Going to RecoverNASDAQ:PROGBiora Therapeutics Inc
10/03/202211:00GlobeNewswire Inc.Progenity Progresses its Drug Delivery System Clinical Device Performance StudiesNASDAQ:PROGBiora Therapeutics Inc
28/02/202211:00GlobeNewswire Inc.Progenity Announces Acceptance of Three Abstracts at Digestive Disease Week 2022NASDAQ:PROGBiora Therapeutics Inc
22/02/202211:00GlobeNewswire Inc.Progenity Shares Two Poster Presentations on Treatment of Gastrointestinal Disorders at ECCO’22NASDAQ:PROGBiora Therapeutics Inc
16/02/202211:00GlobeNewswire Inc.Progenity Shares Oral Presentation on Treatment of Gastrointestinal Disorders at 34th Belgian Week of GastroenterologyNASDAQ:PROGBiora Therapeutics Inc
25/01/202218:05GlobeNewswire Inc.Progenity Strengthens Intellectual Property for Single-Molecule Detection Technology with Additional PatentNASDAQ:PROGBiora Therapeutics Inc
23/01/202205:34TipRanksProgenity: Risks, Red Flags, and Poor FundamentalsNASDAQ:PROGBiora Therapeutics Inc
11/01/202208:30GlobeNewswire Inc.Progenity Announces Oral Presentation on Treatment of Gastrointestinal Disorders at 34th Belgian Week of GastroenterologyNASDAQ:PROGBiora Therapeutics Inc
 Apresentando as notícias mais relevantes sobre:NASDAQ:PROG

Seu Histórico Recente

COIN
TKAGBP
LSE
0I26
Havsfrun Investment Ab
Delayed Upgrade Clock
ADVFN Logo

Brasil
Empresa
Negócios
Popular
Obter o aplicativo

Suporte: (11) 4950 5808 | suporte@advfn.com.br

Ao acessar os serviços da ADVFN você estará de acordo com os Termos e Condições

© 2024 ADVFN PLC - Todos os direitos reservados